As the buzz surrounding weight-loss drugs gets ever louder, analysts at Goldman Sachs Group Inc are predicting a potential US$100 billion market opportunity, with Eli Lilly & Co and Novo Nordisk A/S leading the pack.
Eli Lilly, whose pipeline of drugs includes Mounjaro, is now the world’s biggest healthcare company by market value. Meanwhile, Novo Nordisk became Europe’s most valuable listed company last month, boosted by market enthusiasm for its Ozempic and Wegovy drugs. Shares of both companies have surged this year.
“The chronic weight management market is undergoing an inflection,” Goldman analysts including Chris Shibutani wrote.
Photo: Reuters
They see scope for “solid growth ahead and a peak opportunity that, by our estimates, could ultimately yield some of the highest grossing drugs of all time.”
The analysts see the global market for anti-obesity medicines potentially growing to about US$100 billion in 2030, compared with about US$6 billion in annualized sales earlier this year.
That is based on about 15 million US adults receiving anti-obesity medicine treatment for chronic weight loss management in 2030, out of about 105 million obese or overweight adults in the US. The analysts excluded diabetics from their obesity projections.
Novo Nordisk’s drugs for diabetes and weight loss, a class of medicines known as GLP-1s, share the same active ingredient, semaglutide. They work by suppressing the appetite as well as slowing the movement of food through the digestive tract.
Meanwhile, Lilly’s tirzepatide — already approved for diabetes as Mounjaro — is expected to enter the weight-loss market with an approval for obesity expected by the end of the year.
Consensus expectations suggest Lilly and Novo Nordisk would have a duopoly, in which the two drugmakers would capture about 80 percent of the obesity market in 2030, Goldman analysts said.
“A dominant leadership position can be maintained at this level,” they wrote.
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday obtained the government’s approval to inject an additional US$7.5 billion into its US subsidiary, the Department of Investment Review said in a statement. The department approved TSMC’s application of investing in TSMC Arizona Corp, which is engaged in the manufacturing, sales, testing and design of IC and other semiconductor devices, it said. The latest capital injection follows a US$5 billion investment for TSMC Arizona approved in June. The chipmaker has broken ground on two advanced fabs in Arizona with aggregated investments approved by the department totaling US$24 billion thus far. According to TSMC, the first Arizona
The lethal hack of Hezbollah’s Asian-branded pagers and walkie-talkies has sparked an intense search for the devices’ path, revealing a murky market for older technologies where buyers might have few assurances about what they are getting. While supply chains and distribution channels for higher-margin and newer products are tightly managed, that is not the case for older electronics from Asia where counterfeiting, surplus inventories and complex contract manufacturing deals can sometimes make it impossible to identify the source of a product, analysts and consultants say. The response from the companies at the center of the booby-trapped gadgets that killed 37
FRIENDLY TAKEOVER: While Qualcomm Inc’s proposal to buy some or all of Intel raises the prospect of other competitors, Broadcom Inc is staying on the sidelines Qualcomm Inc has approached Intel Corp to discuss a potential acquisition of the struggling chipmaker, people with knowledge of the matter said, raising the prospect of one of the biggest-ever merger and acquisition deals. California-based Qualcomm proposed a friendly takeover for Intel in recent days, said the sources, who asked not to be identified discussing confidential information. The proposal is for all of the chipmaker, although Qualcomm has not ruled out buying some parts of Intel and selling off others. It is uncertain whether the initial approach would lead to an agreement and any deal is likely to come under close antitrust scrutiny
SECURITY CONCERNS: The proposed ban on Chinese autonomous vehicle software and hardware would go into effect with the 2027 and 2030 model years respectively The US Department of Commerce today is expected to propose prohibiting Chinese software and hardware in connected and autonomous vehicles on US roads due to national security concerns, two sources said. US President Joe Biden’s administration has raised concerns about the collection of data by Chinese companies on US drivers and infrastructure as well as the potential foreign manipulation of vehicles connected to the Internet and navigation systems. The proposed regulation would ban the import and sale of vehicles from China with key communications or automated driving system software or hardware, said the two sources, who declined to be identified because the